Home/ Supplements/ Nmn/ Nicotinamide Mononucleotide 125 mg

Nicotinamide Mononucleotide 125 mg

product on market Capsule SuperSmart Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Nicotinamide Mononucleotide serves as a precursor to NAD+, a coenzyme involved in cellular energy metabolism and DNA repair. Current research providing evidence for its efficacy in humans is limited. The ingredient is generally well-tolerated at the specified dosage.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Nicotinamide Mononucleotide 125 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Vegetarian Capsule(s)
Serving Size
30
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 250.0mg (1 products) 6 studies (A:0, B:2)

Other Ingredients

Acacia Gum
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: Adults. Take 1 vegetarian capsule a day.

Warnings & Precautions

Precautions: Do not exceed the recommended daily dose. This product is a nutritional supplement and should not replace a varied, balanced diet.

Keep out of childrens' reach.

As with any nutritional supplement, you should consult a health professional before taking this product if you are pregnant, breastfeeding or have a health problem.

Formulation Notes

Anti-aging NAD+ booster

Nicotinamide Mononucleotide 125 mg per day

Manufactured in the EU and distributed by: SN Worldwide Unipessoal, Lda

Additional Information

Store away from direct light, heat and humidity.

Metadata

Product Details

UPC / SKU5 453003 826743
DSLD Entry Date2023-11-22
Product TypeNon-Nutrient/Non-Botanical
FormCapsule
DSLD ID285371
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
54
Avg Quality
4
Rct
2
Meta Analysis
2
Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025 PubMed DOI
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024 PubMed DOI
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.) PubMed DOI
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience PubMed DOI
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024 PubMed DOI
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023 PubMed DOI
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →
Compare

Similar Products

View all Nmn products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.